Amphastar Pharmaceuticals, Inc. (AMPH) › Capital ExpendituresAmphastar Pharmaceuticals, Inc. (AMPH) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2012: $23.13M2013: $17.64M2014: $20.50M2015: $16.00M2016: $21.38M2017: $35.10M2018: $46.81M2019: $41.55M2020: $33.85M2021: $27.46M2022: $24.03M2023: $38.17M2024: $41.04M2025: $34.88M$34.88M2012Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$34.88M-15.0%2024$41.04M+7.5%2023$38.17M+58.8%2022$24.03M-12.5%2021$27.46M-18.9%2020$33.85M-18.5%2019$41.55M-11.2%2018$46.81M+33.4%2017$35.10M+64.2%2016$21.38M+33.7%2015$16.00M-22.0%2014$20.50M+16.2%2013$17.64M-23.7%2012$23.13M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share